2020-12-04
|
Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients
unknown status
| post
doi:10.1101/2020.12.02.20242958
|
2021-02-18
|
FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
unknown status
| post
doi:10.1101/2021.02.15.21251623
|
2021-03-08
|
Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA
unknown status
| post
doi:10.1101/2021.03.05.21252946
|
2021-04-04
|
A literature-derived knowledge graph augments the interpretation of single cell RNA-seq datasets
unknown status
| post
doi:10.1101/2021.04.01.438124
|
2021-04-13
|
Case fatality rates for COVID-19 are higher than case fatality rates for motor vehicle accidents for individuals over 40 years of age
unknown status
| post
doi:10.1101/2021.04.09.21255193
|
2021-05-31
|
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
unknown status
| post
doi:10.1101/2021.05.23.21257668
|
2021-05-25
|
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19
published
| post
doi:10.1101/2021.05.23.21257670
|
2021-08-03
|
Diversity of Coronavirus Receptors
unknown status
| post
| CC-BY
doi:10.20944/preprints202108.0071.v1
|
2021-06-10
|
A Literature-Derived Knowledge Graph Augments the Interpretation of Single Cell RNA-seq Datasets
published
| article-journal
| CC-BY
doi:10.3390/genes12060898
|
2021-06-02
|
Type 2 immunity is maintained during cancer associated adipose tissue wasting
published
| article-journal
doi:10.1093/immadv/ltab011
|
2022-02-05
|
SARS-CoV-2 and influenza co-infection throughout the COVID-19 pandemic: An assessment of co-infection rates and cohort characterization
unknown status
| post
doi:10.1101/2022.02.02.22270324
|
2021-04-30
|
Real-world effectiveness of Ad26.COV2.S adenoviral vector vaccine for COVID-19
unknown status
| post
doi:10.1101/2021.04.27.21256193
|
2022-06-08
|
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
published
| article-journal
doi:10.1093/pnasnexus/pgac082
|
2022-04-28
|
Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
published
| article-journal
| CC-BY
doi:10.1093/pnasnexus/pgac042
|
2024-02-01
|
Data from PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
unknown status
| post
| CC-BY
doi:10.1158/1078-0432.c.7054124
|
2024-09-03
|
Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926162.v1
|
2024-09-03
|
Figure S5 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926156
|
2024-09-03
|
Figure S6 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926153.v1
|
2024-09-03
|
Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926147.v1
|
2024-09-03
|
Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926138.v1
|
2024-09-03
|
Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926162
|
2024-09-03
|
Figure S5 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926156.v1
|
2024-09-03
|
Data from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.c.7429399
|
2021-02-23
|
Real-time analysis of a mass vaccination effort via an Artificial Intelligence platform confirms the safety of FDA-authorized COVID-19 vaccines
unknown status
| post
doi:10.1101/2021.02.20.21252134
|
2021-07-05
|
COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance
unknown status
| post
doi:10.1101/2021.07.01.21259833
|
2021-09-07
|
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
unknown status
| post
doi:10.1101/2021.09.04.21263115
|
2021-04-23
|
Cerebral venous sinus thrombosis (CVST) is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state US health system
unknown status
| post
doi:10.1101/2021.04.20.21255806
|
2021-05-19
|
cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes
published
| article-journal
doi:10.1126/scitranslmed.abf5058
|
2021-12-25
|
Genomic diversification of long polynucleotide fragments is a signature of emerging SARS-CoV-2 variants of concern
unknown status
| post
doi:10.1101/2021.12.23.21268315
|
2022-03-07
|
Competitive fitness of emerging SARS-CoV-2 variants is linked to their Distinctiveness relative to preceding lineages from that region
unknown status
| post
doi:10.1101/2022.03.06.22271974
|
2022-08-15
|
Individuals with recent prior SARS-CoV-2 infection are at reduced risk of Omicron infection and associated hospitalization
unknown status
| post
doi:10.1101/2022.08.10.22278641
|
2022-12-01
|
Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions
published
| post
doi:10.1101/2022.11.30.22282831
|
2023-01-23
|
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer
published
| article-journal
doi:10.1084/jem.20220729
|
2023-09-21
|
PD-1 blockade induces reactivation of non-productive T cell responses characterized by NF-kB signaling in patients with pancreatic cancer
published
| article-journal
doi:10.1158/1078-0432.ccr-23-1444
|
2024-09-03
|
Figure S7 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926150.v1
|
2024-09-03
|
Figure S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926165
|
2024-09-03
|
Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926141.v1
|
2024-09-03
|
Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926138
|
2024-09-03
|
Figure S4 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926159.v1
|
2024-09-03
|
Figure S4 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926159
|
2024-09-03
|
Data from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.c.7429399.v1
|
2024-09-03
|
Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926147
|
2021-04-07
|
Female-male differences in COVID vaccine adverse events have precedence in seasonal flu shots: a potential link to sex-associated baseline gene expression patterns
unknown status
| post
doi:10.1101/2021.04.01.21254798
|
2021-08-08
|
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
published
| post
doi:10.1101/2021.08.06.21261707
|
2021-11-09
|
Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records
unknown status
| post
doi:10.1101/2021.11.05.21265961
|
2021-11-29
|
Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: mapping viral variants of cardiac interest
unknown status
| post
doi:10.1101/2021.11.23.469709
|
2021-06-16
|
Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
published
| article-journal
| CC-BY
doi:10.1016/j.jstrokecerebrovasdis.2021.105923
|
2022-06-06
|
On the origin of Omicron's unique Spike gene insertion
unknown status
| post
doi:10.1101/2022.06.03.22275976
|
2022-07-04
|
Quantifying the immunological distinctiveness of emerging SARS-CoV-2 variants in the context of prior regional herd exposure
published
| article-journal
doi:10.1093/pnasnexus/pgac105
|
2022-09-09
|
On the Origins of Omicron's Unique Spike Gene Insertion
published
| article-journal
| CC-BY
doi:10.3390/vaccines10091509
|
2022-05-20
|
Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
published
| article-journal
doi:10.1093/pnasnexus/pgac058
|
2024-07-11
|
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor
published
| article-journal
doi:10.1158/2326-6066.cir-23-1073
|
2024-09-03
|
Figure S6 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926153
|
2024-09-03
|
Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926141
|
2024-09-03
|
Figure S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926168.v1
|
2024-09-03
|
Figure S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926165.v1
|
2024-09-03
|
Figure S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926168
|
2024-09-03
|
Figure S7 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor
unknown status
| post
| CC-BY
doi:10.1158/2326-6066.26926150
|